Similarly, alterations in gut microbiota-derived BAs in chronic hepatitis B patients have been linked to suppressed FXR signaling and impaired hepatoprotection, creating a permissive environment for HCC development. Here, NR1H4 is linked to hepatocellular carcinoma.